Doxorubicin Hydrochloride
Product Images NDC 67457-478

5 FDA label images from Mylan Institutional Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 67457-478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Export 03)

Chemical Structure (Export 03)
Chemical structure of Doxorubicin Hydrochloride showing its molecular formula C27H29NO11 with associated hydrochloride (HCl) and molecular weight of 579.99.*
FDA Label Image

Figure 1 (Export 02)

Figure 1 (Export 02)
A forest plot chart depicting hazard ratios with 95% confidence intervals for five clinical trials comparing Doxorubicin-based treatments to CMF. The chart includes individual trial estimates and a combined estimate from six studies, visually showing relative effectiveness and confidence boundaries around the hazard ratios.*
FDA Label Image

Figure 2 (Export 01)

Figure 2 (Export 01)
A forest plot showing the hazard ratio (95% confidence interval) for six clinical trials related to treatment with doxorubicin-based regimens. The plot compares the effectiveness of doxorubicin against a control, with markers and horizontal lines representing hazard ratios and confidence intervals for each trial, including NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3.*
FDA Label Image

10 mg/vial Bottle Label (Image 02)

10 mg/vial Bottle Label (Image 02)
Packaging label for Doxorubicin Hydrochloride for Injection, USP, 10 mg/vial, manufactured by Mylan Institutional LLC. The label designates the product as a lyophilized, single-dose vial with a cytotoxic agent caution. Storage instructions, inactive ingredients, and preparation guidelines are included on the label. The label also bears multiple barcodes and batch information placeholders.*
FDA Label Image

50 mg/vial Bottle Label (Export 00)

50 mg/vial Bottle Label (Export 00)
Packaging label for Doxorubicin Hydrochloride injection, USP, 50 mg per vial, lyophilized powder by Mylan Institutional LLC. The label states this is a single-dose vial for intravenous use only, with a caution for its cytotoxic nature. It includes storage instructions, active and inactive ingredients, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.